Litigation Details for TOLMAR THERAPEUTICS, INC. v. FORESEE PHARMACEUTICALS CO., LTD. (D.N.J. 2021)
✉ Email this page to a colleague
TOLMAR THERAPEUTICS, INC. v. FORESEE PHARMACEUTICALS CO., LTD. (D.N.J. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-08-20 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | Referred To | Cathy L. Waldor | |
Patents | 8,470,359 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in TOLMAR THERAPEUTICS, INC. v. FORESEE PHARMACEUTICALS CO., LTD.
Details for TOLMAR THERAPEUTICS, INC. v. FORESEE PHARMACEUTICALS CO., LTD. (D.N.J. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-10-24 | 53 | Opinion | that CAMCEVI infringes upon U.S. Patent No. 8,470,359 Defendants move…capture the essence of a thing in a patent application. If patents were always interpreted by their … Id. ¶ 4. Claim 1 of the 359 patent recites: A flowable composition for a … 2021, which alleged filing infringes the 359 patent under 35 U.S.C. § 271(e)(2) and sought a declaratory…PageID: 2551 literally infringe upon the 359 patent. Second, Plaintiff cannot employ the doctrine of | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |